NITI Aayog Releases Eighth Trade Watch Quarterly Highlighting India's Trade Resilience and Pharmaceutical Sector Focus
On 23 June 2026, NITI Aayog released the eighth edition of its Trade Watch Quarterly, covering India's trade performance in Q4 FY 2025-26 (January to March 2026). India's total merchandise and services trade reached $1.84 trillion, expanding by 5.4% year-on-year. Services exports rose by 9%, maintaining a sustained services surplus and positioning India as the world's eighth-largest services exporter in 2025. The report emphasized the pharmaceutical sector as a strategic export pillar linking global competitiveness and health security. Despite moderate merchandise export growth and increased imports, India's trade composition remained stable. The report also noted that the West Asia crisis caused temporary supply shocks, underlining the need for diversified import sources and export markets to strengthen trade resilience.
On this page

Key Facts
- Trade Watch Quarterly 8th edition released on 23 June 2026 by NITI Aayog in New Delhi.
- Period covered: Fourth quarter of FY 2025-26 (January–March 2026).
- India's total merchandise and services trade was $1.84 trillion, showing 5.4% year-on-year growth.
- Services exports grew by 9%, outpacing import growth, sustaining a services surplus during the quarter.
- India retained its position as world’s eighth-largest services exporter in 2025.
- The thematic focus in this edition is on the pharmaceutical sector, critical to global competitiveness and health security.
- Merchandise exports growth moderated, while imports increased, with overall trade composition remaining stable.
- The West Asia geopolitical crisis was characterized as a temporary supply shock, emphasizing the need for trade diversification.
Background & Context
The Trade Watch Quarterly is a periodic publication by NITI Aayog monitoring India’s merchandise and services trade performance and external sector developments. The eighth quarter report highlights the resilience of India's external trade amid global economic uncertainties, spotlighting the pharmaceutical sector's substantial role in India’s exports. Supply disruptions linked to geopolitical tensions in West Asia underscore the strategic importance of diversifying trade partners and markets to mitigate risks and ensure supply chain stability.
Why This Matters for Exams / Exam Relevance
For students preparing for competitive exams, understanding current trade statistics and sectoral highlights helps with questions on India’s economic performance, international trade rankings, and policy initiatives. The pharmaceutical sector's prominence reflects India’s growing global role in healthcare, and insights about the West Asia crisis provide context for questions on geopolitical impacts on trade and economic security.
Points to Remember
- Date of release: 23 June 2026.
- Trade period: Q4 FY 2025-26 (Jan-Mar 2026).
- Total trade value: $1.84 trillion with 5.4% annual growth.
- Services exports grew 9%, maintaining a services surplus.
- India ranked as world’s eighth-largest services exporter in 2025.
- Pharmaceutical sector is a major export component and focus area.
- Merchandise exports moderated; imports increased in Q4 FY 2025-26.
- West Asia crisis seen as temporary supply shock requiring trade diversification.
Sources & Further Reading
| Document / Website | Link |
|---|---|
| NITI Aayog Releases Eighth Trade Watch Quarterly | Open NITI Aayog Releases Eighth Trade Watch Quarterly ↗www.gktoday.in |
| India’s pharma sector bullish on export growth | Open India’s pharma sector bullish on export growth ↗www.ibef.org |
| Amidst West Asia pressures, India’s goods exports grew 14% in April 2026 | Open Amidst West Asia pressures, India’s goods exports grew 14% in April 2026 ↗www.thehindu.com |